Evolus, Inc. (EOLS)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Total net revenues | 69,387 | 68,522 | 61,085 | |
| Gross profit | 45,320 | 46,655 | - | |
| Depreciation and amortization | - | - | 1,087 | |
| Cost of goods sold | 24,067 | 21,867 | 18,223 | |
| Selling, general and administrative | 56,675 | 56,640 | 52,506 | |
| Research and development | 1,837 | 2,212 | 2,314 | |
| Revaluation of contingent royalty obligation payable to evolus founders | 3,914 | -2,151 | -2,428 | |
| Depreciation and amortization | 932 | 824 | - | |
| Total operating expenses | 55,530 | 61,827 | 76,558 | |
| Loss from operations | -10,210 | -15,172 | -15,473 | |
| Interest income | 479 | 710 | 928 | |
| Interest expense | 7,207 | 4,415 | 4,764 | |
| Other income (expense), net | -151 | 57 | 273 | |
| Loss before income taxes | -17,089 | -18,820 | -19,036 | |
| Income tax expense | 53 | 72 | 134 | |
| Net loss | -17,142 | -18,892 | -19,170 | |
| Currency translation adjustment | 240 | - | - | |
| Unrealized income (loss), net of tax | - | 66 | -88 | |
| Comprehensive loss | -16,902 | -18,826 | -19,258 | |
| Net loss per share, basic (in dollars per share) | -0.27 | -0.3 | -0.3 | |
| Net loss per share, diluted (in dollars per share) | -0.27 | -0.3 | -0.3 | |
| Weighted-average shares outstanding used to compute basic net loss per share (in shares) | 64,539,291 | 63,696,627 | 63,148,968 | |
| Weighted-average shares outstanding used to compute diluted net loss per share (in shares) | 64,539,291 | 63,696,627 | 63,148,968 | |